Cour Pharmaceuticals Development
Executives
View the org chart displaying its 10 main executives
Most searched biographies at Cour Pharmaceuticals Development
- John Puisis, Chief Executive Officer and President
- Robert Carey, Lead Independent Director
- Sarah Longoria, Chief People Officer
Popular executive movements at Cour Pharmaceuticals Development
- Paul Peloso has joined the company as Chief Medical Officer (posted on May 22 2024).
Create your alert
to follow the executive moves at Cour Pharmaceuticals Development.
Pharmaceuticals
Cour Pharmaceuticals Development has 1,859 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Cour Pharmaceuticals Development
- COUR Pharmaceuticals Announces Biotechnology Industry Veteran Robert F. Carey Joins Board of Directors as Lead Independent Director
- COUR Pharmaceuticals Appoints Dannielle Appelhans as Chief Operating Officer
- COUR Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Myasthenia Gravis
- COUR Pharmaceuticals Secures $105 Million in Series A Financing Co-Led by Lumira Ventures and Alpha Wave Ventures
- Press Releases - COUR Pharmaceuticals
Social media about Cour Pharmaceuticals Development
- Cour Pharmaceuticals Development on Wikipedia, Google News & Yahoo Finance
- Cour Pharmaceuticals Development on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including John Puisis 
Call Cour Pharmaceuticals Development at +1 501...
